Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 28,456 shares at $34.30 ($977K) on 2022-02-23, disclosed to the SEC on 2022-02-24.
Open-market sale of $977k ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.30 | 13,956 | $479K | 49.0% |
| 2 | $34.30 | 13,956 | $479K | 49.0% |
| 3 | $35.32 | 544 | $19K | 2.0% |
| Total | $34.32 avg | 28,456 | $977K | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-01-26 | $1.0M | — | Filing → |